Co-Authors
This is a "connection" page, showing publications co-authored by Guillermo Umpierrez and David Klonoff.
Connection Strength
4.900
-
Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia. J Diabetes Sci Technol. 2021 09; 15(5):1181-1187.
Score: 0.952
-
Hospital Diabetes Meeting 2020. J Diabetes Sci Technol. 2020 09; 14(5):928-944.
Score: 0.897
-
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity. Metabolism. 2020 07; 108:154224.
Score: 0.876
-
Response to Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589. Diabetes Care. 2019 04; 42(4):e66-e67.
Score: 0.816
-
Response to Comment on Umpierrez and Klonoff. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 2018;41:1579-1589. Diabetes Care. 2019 01; 42(1):e15.
Score: 0.802
-
Association Between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients With COVID-19: A Multicenter, Retrospective Hospital-Based Analysis. Diabetes Care. 2021 02; 44(2):578-585.
Score: 0.230
-
Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline. J Diabetes Sci Technol. 2020 11; 14(6):1035-1064.
Score: 0.226
-
Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol. 2020 Jul; 14(4):822-832.
Score: 0.055
-
Consensus Statement on Inpatient Use of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2017 09; 11(5):1036-1044.
Score: 0.045